AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Cash from Financing (Quarterly): 2.00M for Sept. 30, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 2.00M |
| June 30, 2023 | 2.00M |
| March 31, 2023 | 11.50M |
| December 31, 2022 | 1.50M |
| September 30, 2022 | 1.00M |
| June 30, 2022 | 2.00M |
| March 31, 2022 | 1.50M |
| December 31, 2021 | 1.50M |
| September 30, 2021 | 2.00M |
| June 30, 2021 | 1.50M |
| March 31, 2021 | 2.246M |
| December 31, 2020 | 0.992M |
| Date | Value |
|---|---|
| September 30, 2020 | 1.977M |
| June 30, 2020 | 2.807M |
| March 31, 2020 | 0.185M |
| December 31, 2019 | 1.287M |
| September 30, 2019 | 0.487M |
| June 30, 2019 | -0.009M |
| March 31, 2019 | 4.50M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.263M |
| June 30, 2018 | 5.00M |
| March 31, 2018 | 0.737M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.009M
Minimum
Jun 2019
11.50M
Maximum
Mar 2023
2.026M
Average
1.50M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
| Homology Medicines Inc (DELISTED) | 0.014M |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.864M |
| Free Cash Flow | -7.069M |
| Free Cash Flow Per Share (Quarterly) | -1.727 |
| Free Cash Flow to Equity (Quarterly) | 28.93M |
| Free Cash Flow Yield | -59.02% |